At the recent Radiological Society of North America (RSNA) conference, Siemens Healthineers showcased its latest innovations in mammography and interventional technology. The company introduced new tools and solutions designed to improve the diagnosis and treatment of breast cancer, as well as enhance interventional radiology procedures.
In the area of mammography, Siemens Healthineers introduced its new Mammomat Fusion mammography system, which combines 2D and 3D imaging capabilities to provide more accurate diagnoses. The system uses artificial intelligence (AI) to help detect breast cancer earlier and more accurately, reducing the need for unnecessary biopsies. Additionally, the company showcased its new Syngo Mammo CAD (Computer-Aided Detection) software, which uses AI to analyze mammography images and highlight potential abnormalities.
Siemens Healthineers also highlighted its advancements in interventional technology, including its new Cios Flow mobile C-arm, which provides high-quality imaging during surgical procedures. The Cios Flow features a new detector design that allows for faster and more precise imaging, reducing radiation exposure for patients and clinicians. The company also showcased its new Artis icono angiography system, which provides high-resolution imaging during interventional procedures, such as stroke treatment and tumor embolization.
Another key area of focus for Siemens Healthineers at RSNA was its new teamplay digital health platform, which enables healthcare providers to access and analyze data from various medical imaging modalities. The platform uses AI and machine learning to analyze data and provide insights on patient outcomes, allowing clinicians to make more informed treatment decisions.
Overall, Siemens Healthineers’ showcase at RSNA demonstrated the company’s commitment to innovation and improving patient outcomes in the fields of mammography and interventional radiology. The company’s new technologies and solutions have the potential to improve the diagnosis and treatment of breast cancer, as well as enhance the safety and efficacy of interventional procedures. By leveraging AI, machine learning, and digital health platforms, Siemens Healthineers is helping to shape the future of medical imaging and healthcare.
The new technologies showcased by Siemens Healthineers at RSNA have the potential to make a significant impact on patient care and outcomes. With its focus on innovation and customer needs, Siemens Healthineers is well-positioned to continue leading the way in the development of medical imaging technologies. The company’s commitment to improving patient outcomes and enhancing the quality of care is evident in its new products and solutions, which are designed to address some of the most pressing challenges in healthcare today.